Patients taking Chantix had a heightened risk for hospitalizations and ED visits due to adverse cardiovascular events, according to findings published in the American Journal of Respiratory and Critical Care Medicine.
“[Chantix (varenicline, Pfizer)] has been shown to improve smoking cessation rates more effectively than bupropion, single forms of nicotine replacement, nonpharmacological methods and placebo in randomized clinical trials, but evidence regarding its real world cardiovascular and neuropsychiatric safety has been inconsistent,” Andrea Gershon MD, MSc, FRCP, associate professor of Medicine, University of Toronto, told Healio Medicine.
No commercial support for this activity.
American Heart Association Scientific Sessions
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
©2018 Healio All Rights Reserved.